10-Q: Utz Brands Reports Mixed Results in Q2 2024 Amid Strategic Divestitures and Cost Management Efforts
Summary
- Utz Brands reported a net sales decrease of 1.8% for the thirteen weeks ended June 30, 2024, compared to the same period in 2023, with net sales reaching $356.2 million.
- The company's gross profit margin increased to 35.0% for the thirteen weeks ended June 30, 2024, up from 32.4% in the prior year period.
- Selling, distribution, and administrative expenses decreased by 8.6% for the thirteen weeks ended June 30, 2024, primarily due to prior year impairment and severance costs.
- The company recognized a gain on sale of assets of $2.4 million for the thirteen weeks ended June 30, 2024.
- For the twenty-six weeks ended June 30, 2024, net sales decreased by 1.6% to $702.7 million compared to $714.3 million in the same period of 2023.
- Gross profit margin for the twenty-six weeks ended June 30, 2024, was 34.8%, compared to 31.1% for the same period in 2023.
- The company reported a net income of $25.4 million for the thirteen weeks ended June 30, 2024, compared to a net loss of $8.6 million in the same period of 2023.
- Net income for the twenty-six weeks ended June 30, 2024, was $27.8 million, compared to a net loss of $23.0 million in the same period of 2023.
- The company completed the sale of the Good Health and R.W. Garcia brands and related manufacturing facilities for $167.5 million, recognizing a gain of $44.0 million.
- Utz also sold its Berlin, PA, and Fitchburg, MA manufacturing facilities for $18.5 million, recognizing a gain of $4.3 million.
Sentiment
Score: 7
Explanation: The document shows a mixed picture with positive improvements in profitability and strategic divestitures, but also a decrease in net sales. The overall sentiment is cautiously optimistic due to the positive financial adjustments and strategic moves.
Highlights
- Net sales decreased by 1.8% for the thirteen weeks ended June 30, 2024, and 1.6% for the twenty-six weeks ended June 30, 2024, compared to the same periods in 2023.
- Gross profit margin improved to 35.0% for the thirteen weeks ended June 30, 2024, and 34.8% for the twenty-six weeks ended June 30, 2024.
- The company recognized a significant gain of $44.0 million from the sale of the Good Health and R.W. Garcia brands.
- Utz sold its Berlin, PA, and Fitchburg, MA manufacturing facilities for $18.5 million, recognizing a gain of $4.3 million.
- The company refinanced its Term Loan B, reducing the interest rate and recording a loss on debt extinguishment of $1.3 million.
- The company made a $141.0 million accelerated payment on its Term Loan B and $17.7 million payment on its Real Estate Term Loan during the twenty-six weeks ended June 30, 2024.
- The company purchased an indefinite life intangible right for use of a third party brand name for $9.2 million.
- The company's weighted average interest rate for the twenty-six weeks ended June 30, 2024 was 5.8%, up from 5.7% during the twenty-six weeks ended July 2, 2023.
Positives
- Gross profit margins increased significantly, indicating improved operational efficiency and cost management.
- The company generated substantial gains from strategic divestitures, improving overall profitability.
- Selling, distribution, and administrative expenses decreased, reflecting cost-cutting measures.
- The refinancing of the Term Loan B reduced the interest rate, potentially lowering future interest expenses.
- The company made significant payments on its Term Loan B and Real Estate Term Loan, reducing overall debt.
- Power brand volume increased by approximately 4% for the thirteen weeks ended June 30, 2024, and for the twenty-six weeks ended June 30, 2024.
Negatives
- Net sales decreased for both the thirteen and twenty-six week periods, indicating a potential decline in overall demand or market share.
- The company recorded a loss on debt extinguishment of $1.3 million related to the refinancing of its Term Loan B.
- The company's weighted average interest rate increased slightly, potentially increasing interest expenses.
- Foundation brand volume decreased by approximately 10% for the thirteen weeks ended June 30, 2024, and 13% for the twenty-six weeks ended June 30, 2024.
Risks
- The company faces risks related to commodity cost increases, which may adversely impact net income.
- Rising transportation costs and labor costs may negatively impact profitability.
- The company's variable rate indebtedness is subject to interest rate fluctuations, which could increase interest expenses.
- The company's ability to maintain sales levels at higher prices is uncertain.
- The company's effective tax rate for the twenty-six weeks ended June 30, 2024 was 47.5%, impacted by the sale of certain assets and brands.
Future Outlook
The company expects to continue to manage costs and optimize its supply chain. The company will operate under transition services agreements with Our Home which end during the first half of 2025. The company will also operate under reciprocal co-manufacturing agreements with Our Home.
Industry Context
The company operates in the competitive salty snack industry, which is experiencing consistent retail sales growth. The company is the second-largest producer of branded salty snacks in its core geographies. The company is focused on managing costs and optimizing its supply chain to maintain profitability.
Comparison to Industry Standards
- The company's gross profit margin of 35.0% for the thirteen weeks ended June 30, 2024, and 34.8% for the twenty-six weeks ended June 30, 2024, is a positive sign compared to the industry average, indicating effective cost management.
- The company's strategic divestitures, such as the sale of the Good Health and R.W. Garcia brands, are in line with industry trends of companies focusing on core brands and streamlining operations.
- The company's focus on cost management and productivity initiatives is consistent with industry best practices for maintaining profitability in a competitive market.
- The company's debt refinancing and payments are a positive step towards improving its financial health, which is a common goal for companies in the industry.
Stakeholder Impact
- Shareholders may see a positive impact from the improved profitability and strategic divestitures.
- Employees may be affected by the ongoing cost management initiatives and changes in manufacturing operations.
- Customers may experience changes in product availability and distribution due to the divestitures.
- Suppliers may be impacted by changes in the company's supply chain and manufacturing operations.
- Creditors may view the debt refinancing and payments as a positive sign of improved financial health.
Next Steps
- The company will continue to operate under transition services agreements with Our Home which end during the first half of 2025.
- The company will continue to operate under reciprocal co-manufacturing agreements with Our Home.
- The company will continue to evaluate its financing strategy to meet its shortand longer-term capital needs.
Legal Proceedings
- The company is involved in litigation and other matters incidental to the conduct of its business, the results of which, in the opinion of management, are not likely to be material to the company's financial condition, results of operations or cash flows.
Related Party Transactions
- The company sold certain assets and brands to affiliates of Our Home, an operating company of Better-for-You brands.
Key Dates
- 2020-06-05: Date of the Business Combination Agreement between Collier Creek Cayman and Utz Brands Holdings, LLC.
- 2020-08-28: Closing date of the business combination, when Utz Brands, Inc. was formed.
- 2023-12-31: End of the 2023 fiscal year.
- 2024-02-05: Date of the Good Health and R.W. Garcia Sale.
- 2024-03-25: Date of amendment to the Certificate of Incorporation.
- 2024-04-17: Date of amendment to the Term Loan B and ABL facility.
- 2024-04-22: Date of the Manufacturing Facilities Sale.
- 2024-06-30: End of the second quarter of 2024.
- 2024-07-29: Date of share information.
- 2024-12-29: End of the 2024 fiscal year.
Keywords
Filings with Classifications
Quarterly Report
- Gross profit margin decreased to 33.6% due to promotional investments and increased spending on capacity expansions and distribution growth.
Annual Results
- Gross profit margin increased significantly to 35.1% from 31.7%.
- Adjusted EBITDA increased to $200.2 million, representing 14.2% of net sales.
- Net income attributable to controlling interest was $15.974 million, compared to a net loss of $24.937 million in the previous year.
SEC Form 4 Filing
- A large sale of shares by a major holder is generally viewed negatively by the market.
Quarterly Report
- The company's gross profit margin improved significantly, indicating better operational efficiency and cost management.
- The company's strategic divestitures generated substantial cash and reduced debt, improving its financial position.
Quarterly Report
- The company's adjusted earnings per share increased by 23.5%, which is a better result than the prior year period.
- The company's adjusted EBITDA margin expanded by 80 basis points, indicating improved profitability.
- The company reaffirmed its full-year outlook, suggesting confidence in future performance.
Quarterly Report
- The company's gross profit margin improved significantly, indicating better operational efficiency.
- The company generated substantial gains from strategic divestitures, improving overall profitability.
- The company's net income improved significantly compared to the same period last year.
Quarterly Report
- The company's adjusted earnings per share increased by 46.2%, significantly exceeding expectations.
- The company's adjusted EBITDA increased by 10.0%, demonstrating strong profitability improvements.
- The company raised its full-year adjusted earnings per share outlook from 23%-28% to 28%-32%.
Quarterly Report
- The company's net sales decreased by 1.4% year-over-year, indicating a worse performance than expected.
- The company experienced a net loss attributable to controlling interest of $3.99 million, indicating a worse performance than expected.
Quarterly Report
- The company's net income improved significantly from a loss to a profit.
- Adjusted earnings per share increased by 27.3%, exceeding expectations.
- The company raised its adjusted earnings per share outlook for the full year.
Press Release
- The company expects the plant disposition to be accretive to its Adjusted Earnings Per Share in 2024.
- The term loan repricing is expected to save approximately $2 million annually in cash interest expense.
Proxy Statement
- The company's GAAP net loss moved from $(14.0 million) to ($40.0 million) in fiscal year 2023.
- Sales results were below expectations set at the beginning of 2023.
Quarterly Report
- The company reported a net loss of $33.2 million in Q4 2023 compared to a net income of $13.8 million in the same period last year, indicating worse than expected results.
- The full-year net loss of $40.0 million was also worse than the net loss of $14.0 million in the prior year.
Merger Announcement
- The transaction is expected to accelerate the company's deleveraging timeline by a full year.
- The company expects the transaction to be accretive to its Adjusted Earnings per Share in 2024.
- The company is narrowing its fiscal-year 2023 Adjusted EBITDA outlook range to growth of 9.5% to 10.0%.
Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.